213 related articles for article (PubMed ID: 22309877)
1. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols.
Alviggi C; Humaidan P; Ezcurra D
Reprod Biol Endocrinol; 2012 Feb; 10():9. PubMed ID: 22309877
[TBL] [Abstract][Full Text] [Related]
2. Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.
Bosch E; Ezcurra D
Reprod Biol Endocrinol; 2011 Jun; 9():82. PubMed ID: 21693025
[TBL] [Abstract][Full Text] [Related]
3. Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve.
Di Paola R; Garzon S; Giuliani S; Laganà AS; Noventa M; Parissone F; Zorzi C; Raffaelli R; Ghezzi F; Franchi M; Zaffagnini S
Arch Gynecol Obstet; 2018 Nov; 298(5):1029-1035. PubMed ID: 30242498
[TBL] [Abstract][Full Text] [Related]
4. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
5. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
La Marca A; Sunkara SK
Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
[TBL] [Abstract][Full Text] [Related]
6. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
[TBL] [Abstract][Full Text] [Related]
7. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
8. Discordance between day-3 follicle stimulating hormone & anti-Müllerian hormone is predictive of clinical pregnancy during fertility treatment.
Butler WJ; Pico A; Hawkins KC; Younis AI
Gynecol Endocrinol; 2021 Sep; 37(9):798-801. PubMed ID: 33355011
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
[TBL] [Abstract][Full Text] [Related]
10. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269
[TBL] [Abstract][Full Text] [Related]
11. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
12. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
13. Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol.
Wu S; Li Y; Wu G; Wu H
BMC Womens Health; 2023 Apr; 23(1):202. PubMed ID: 37118751
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
Andersen AN; Witjes H; Gordon K; Mannaerts B;
Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
[TBL] [Abstract][Full Text] [Related]
15. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
16. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
18. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.
Iliodromiti S; Anderson RA; Nelson SM
Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055
[TBL] [Abstract][Full Text] [Related]
19. The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure.
Motawi TMK; Rizk SM; Maurice NW; Maged AM; Raslan AN; Sawaf AH
J Assist Reprod Genet; 2017 Dec; 34(12):1659-1666. PubMed ID: 28825151
[TBL] [Abstract][Full Text] [Related]
20. Do we overlook predictive factors in Poseidon 1 patients? A retrospective analysis co-evaluating antral follicle counts & diameters.
Uncu G; Aslan K; Cakir C; Avci B; Kasapoglu I; Alviggi C
J Ovarian Res; 2024 Jan; 17(1):1. PubMed ID: 38169411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
